New weapons in the battle against fake drugs

By Abhai Pandey,Lex Orbis
0
1052
LinkedIn
Facebook
Twitter
Whatsapp
Telegram
Copy link

Counterfeiting has become an enigma for the world pharmaceutical trade. Estimated rates of counterfeiting keep varying with the investment and ease to produce counterfeit goods, although it is certain that counterfeiting accounts for a significant component of the global trade.

Abhai Pandey, Partner, Lex Orbis IP Practice
Abhai Pandey
Partner
Lex Orbis

The most obvious effect for a company whose products are being counterfeited is the loss of sales along with the dilution of the brand in the case of niche products. Loss of goodwill is also a factor as consumers generally blame the legitimate manufacturer for lack of quality when they unwittingly buy a counterfeit thinking it to be genuine.

Seizures by customs, law enforcement and test purchases are some ways in which companies become aware that their products are being counterfeited and whether a continuing problem is getting worse.

You must be a subscribersubscribersubscribersubscriber to read this content, please subscribesubscribesubscribesubscribe today.

For group subscribers, please click here to access.
Interested in group subscription? Please contact us.

你需要登录去解锁本文内容。欢迎注册账号。如果想阅读月刊所有文章,欢迎成为我们的订阅会员成为我们的订阅会员

已有集团订阅,可点击此处继续浏览。
如对集团订阅感兴趣,请联络我们

Abhai Pandey is a lawyer with LEX ORBIS IP Practice, a law firm specializing in intellectual property issues

Lex_Orbis_logo-CMYK

Lex Orbis IP Practice

709/710, Tolstoy House, 15-17, Tolstoy Marg

New Delhi – 110 001

India

Tel: +91 11 2371 6565

Fax: +91 11 2371 6556

Email: mail@lexorbis.com

www.lexorbis.com

LinkedIn
Facebook
Twitter
Whatsapp
Telegram
Copy link